2023
DOI: 10.1089/dia.2022.0422
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
2
0
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 24 publications
0
2
0
2
Order By: Relevance
“…This is a secondary outcome analysis of the ULTRAFLEXI‐1 study, which compared within the primary outcome the effect of insulin glargine U‐300 and insulin degludec U‐100 on glycaemic control 11 . The study was a randomized, single‐centre, four‐period randomized crossover trial conducted in people with T1D.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…This is a secondary outcome analysis of the ULTRAFLEXI‐1 study, which compared within the primary outcome the effect of insulin glargine U‐300 and insulin degludec U‐100 on glycaemic control 11 . The study was a randomized, single‐centre, four‐period randomized crossover trial conducted in people with T1D.…”
Section: Methodsmentioning
confidence: 99%
“…This is a secondary outcome analysis of the ULTRAFLEXI-1 study, which compared within the primary outcome the effect of insulin glargine U-300 and insulin degludec U-100 on glycaemic control. 11 The study was a randomized, single-centre, four-period randomized crossover trial conducted in people with T1D. Participants were randomly allocated to one of four trial arms in a crossover fashion (insulin glargine U-300 100% and 75% dose, respectively, and insulin degludec 100% and 75% dose).…”
Section: Methodsmentioning
confidence: 99%
“…Die Daten zeigten jedoch, dass eine Reduktion der Dosis um 25 % nur für Insulin Degludec U100 zwingend notwendig ist, nicht jedoch für Insulin Glargin U300, um das Hypoglykämierisiko für die folgenden 24 h nach demSport signifikant zu reduzierten. [19]. Bei der Benutzung von Insulinpumpen ist eine Reduktion von 50-80 % 90 min vor dem Training oft eine gute Wahl.…”
Section: Anpassung Des Basalinsulinsunclassified
“…Die Daten zeigten jedoch, dass eine Reduktion der Dosis um 25 % nur für Insulin Degludec U100 zwingend notwendig ist, nicht jedoch für Insulin Glargin U300, um das Hypoglykämierisiko für die folgenden 24 h nach dem Sport signifikant zu reduzierten. [19]. Bei der Benutzung von Insulinpumpen ist eine Reduktion von 50-80 % 90 min vor dem Training oft eine gute Wahl.…”
Section: Anpassung Des Basalinsulinsunclassified